Literature DB >> 31840205

Temporal VEGFA responsive genes in HUVECs: Gene signatures and potential ligands/receptors fine-tuning angiogenesis.

P Sunitha1, Rajesh Raju2, C K Sajil1, C S Abhinand1, Achuthsankar S Nair1, Oommen V Oommen1, V S Sugunan1, P R Sudhakaran3.   

Abstract

Vascular Endothelial Growth Factor-A (VEGFA) signaling is crucial to the cellular processes involved in angiogenesis. Previously, we assembled a network of molecular reactions induced by VEGFA in human umbilical vein endothelial cell populations. Considering transcriptome as a read-out of the transcriptional and epigenomic regulatory network, we now present an analysis of VEGFA-induced temporal transcriptome datasets from 6 non-synchronized studies. From these datasets, applying a confidence criterion, a set of early VEGFA-responsive signature genes were derived and evaluated for their co-expression potential with respect to multiple cancer gene expression datasets. Further, inclusive of a set of ligand-receptor pairs, a list of ligand and receptor signaling systems that potentially fine-tune the endothelial cell functions subsequent to VEGFA signaling were also derived. We believe that a number of these signaling systems would concurrently and/or hierarchically fine-tune the signaling network of endothelial cell populations towards the processes associated with angiogenesis through autocrine, paracrine, juxtacrine, and matricrine modes. By further analysis of published literature on VEGFA signaling, we also present an improved update-version of our previous VEGFA signaling network model in endothelial cells as a platform for analysis of cross-talk with these signaling systems.

Entities:  

Keywords:  Angiogenesis; Cross-talk; Gene expression; HUVECs; Signature; VEGF

Year:  2019        PMID: 31840205      PMCID: PMC6946775          DOI: 10.1007/s12079-019-00541-7

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.908


  53 in total

Review 1.  Angiogenesis in health and disease.

Authors:  Peter Carmeliet
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 2.  A review on pro- and anti-angiogenic factors as targets of clinical intervention.

Authors:  Diane Bouïs; Yoka Kusumanto; Coby Meijer; Nanno H Mulder; Geke A P Hospers
Journal:  Pharmacol Res       Date:  2006-02       Impact factor: 7.658

Review 3.  The vasculature and limb development.

Authors:  A I Caplan
Journal:  Cell Differ       Date:  1985-02

Review 4.  Angiogenesis in cancer and other diseases.

Authors:  P Carmeliet; R K Jain
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 5.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

Review 6.  Angiogenesis after cerebral ischemia.

Authors:  Heike Beck; Karl H Plate
Journal:  Acta Neuropathol       Date:  2009-01-14       Impact factor: 17.088

Review 7.  Antiangiogenic therapy for cancer: an update.

Authors:  Belal Al-Husein; Maha Abdalla; Morgan Trepte; David L Deremer; Payaningal R Somanath
Journal:  Pharmacotherapy       Date:  2012-12       Impact factor: 4.705

8.  VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis.

Authors:  Chandran S Abhinand; Rajesh Raju; Sasikumar J Soumya; Prabha S Arya; Perumana R Sudhakaran
Journal:  J Cell Commun Signal       Date:  2016-09-12       Impact factor: 5.782

9.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

10.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937

View more
  5 in total

1.  Expression Profiling Identifies TWIST2 Target Genes in Setleis Syndrome Patient Fibroblast and Lymphoblast Cells.

Authors:  Noe E Crespo; Alexandra Torres-Bracero; Jessicca Y Renta; Robert J Desnick; Carmen L Cadilla
Journal:  Int J Environ Res Public Health       Date:  2021-02-19       Impact factor: 3.390

2.  Protrudin regulates FAK activation, endothelial cell migration and angiogenesis.

Authors:  Amita Arora; Annukka M Kivelä; Ling Wang; Rimante Minkeviciene; Juuso H Taskinen; Birong Zhang; Annika Koponen; Jing Sun; Michiko Shirane; You Zhou; Pirta Hotulainen; Camilla Raiborg; Vesa M Olkkonen
Journal:  Cell Mol Life Sci       Date:  2022-04-04       Impact factor: 9.207

3.  A multi-cellular molecular signaling and functional network map of C-C motif chemokine ligand 18 (CCL18): a chemokine with immunosuppressive and pro-tumor functions.

Authors:  Anjana Aravind; Akhina Palollathil; D A B Rex; Kenkere M Kiran Kumar; Manavalan Vijayakumar; Rohan Shetty; Jalaluddin Akbar Kandel Codi; Thottethodi Subrahmanya Keshava Prasad; Rajesh Raju
Journal:  J Cell Commun Signal       Date:  2021-07-01       Impact factor: 5.908

4.  Identification of Hub Genes and Key Pathways Associated with Anti-VEGF Resistant Glioblastoma Using Gene Expression Data Analysis.

Authors:  Kesavan R Arya; Ramachandran P Bharath Chand; Chandran S Abhinand; Achuthsankar S Nair; Oommen V Oommen; Perumana R Sudhakaran
Journal:  Biomolecules       Date:  2021-03-09

5.  Endothelial Notch signaling directly regulates the small GTPase RND1 to facilitate Notch suppression of endothelial migration.

Authors:  Bhairavi Swaminathan; Seock-Won Youn; L A Naiche; Jing Du; Stephanie R Villa; Jordan B Metz; Huijuan Feng; Chaolin Zhang; Raphael Kopan; Peter A Sims; Jan K Kitajewski
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.